Laboratorios Farmaceuticos Rovi, S.A. Price Chart
Laboratorios Farmaceuticos Rovi, S.A. 41L.SG Financial and Trading Overview
| Laboratorios Farmaceuticos Rovi, S.A. stock price | 87 EUR |
| Previous Close | 42.5 EUR |
| Open | 42.32 EUR |
| Bid | 42.36 EUR x 2000000 |
| Ask | 42.62 EUR x 2000000 |
| Day's Range | 42.32 - 42.32 EUR |
| 52 Week Range | 35.44 - 61 EUR |
| Volume | 0 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 2.4B EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 86.54397 |
| EPS (TTM) | 0.49 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
41L.SG Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | 86.54397 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Laboratorios Farmaceuticos Rovi, S.A. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 61 EUR |
| 52 Week Low | 35.44 EUR |
| 50-Day Moving Average | 41.34 EUR |
| 200-Day Moving Average | 40.81 EUR |
41L.SG Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.08 |
| Trailing Annual Dividend Yield | 0.18% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 171.06M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Laboratorios Farmaceuticos Rovi, S.A. Stock
What is a current 41L.SG stock price?
Laboratorios Farmaceuticos Rovi, S.A. 41L.SG stock price today per share is 87 EUR.
How to purchase Laboratorios Farmaceuticos Rovi, S.A. stock?
You can buy 41L.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Laboratorios Farmaceuticos Rovi, S.A.?
The stock symbol or ticker of Laboratorios Farmaceuticos Rovi, S.A. is 41L.SG.
How many shares does Laboratorios Farmaceuticos Rovi, S.A. have in circulation?
The max supply of Laboratorios Farmaceuticos Rovi, S.A. shares is 56.7M.
What is Laboratorios Farmaceuticos Rovi, S.A. Price to Earnings Ratio (PE Ratio)?
Laboratorios Farmaceuticos Rovi, S.A. PE Ratio is 177.91411000 now.
What was Laboratorios Farmaceuticos Rovi, S.A. earnings per share over the trailing 12 months (TTM)?
Laboratorios Farmaceuticos Rovi, S.A. EPS is 0.49 EUR over the trailing 12 months.